[Toxoplasmosis and generalized mycosis after treatment of chronic myelosis (author's transl)].
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications* / Q000473:pathology; D001232:Aspergillus fumigatus; D001344:Autopsy; D002176:Candida albicans; D002177:Candidiasis / Q000150:complications*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000473:pathology; D008297:Male; D014123:Toxoplasmosis / Q000150:complications* / Q000473:pathology
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D005938:Glucocorticoids
Toxoplasmose und generalisierte Mykose nach behandelter chronischer Myelose.